Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Region: Trend Forecast and Growth Opportunity

Global pharmaceutical contract manufacturing market will reach $184.8 billion by 2030, growing by 6.2% annually over 2020-2030 driven by increasing dependence on contract manufacturing organizations due to improved efficiency and productivity amid COVID-19 pandemic.
Highlighted with 87 tables and 85 figures, this 173-page report “Global Pharmaceutical Contract Manufacturing Market 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical contract manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract manufacturing market in every aspect of the classification from perspectives of Category, Product, Phase, Type, Therapeutic Application, and Region.

Based on Category, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Industry
• Biopharmaceutical Industry

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Active Pharmaceutical Ingredients (API)
• Branded API Manufacturing
• Generic API Manufacturing
Finished Dosage Formulations (FDF)
• Solid Dosage
• Oral Liquids
• Parenteral/Injectables
• Other FDFs
Secondary Packaging

Based on Phase, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Clinical Manufacturing
• Commercial Manufacturing

Based on Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Sterile Products
• Non-Sterile Products

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Phase, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global pharmaceutical contract manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Aenova Group
Baxter BioPharma Solutions
Boehringer Ingelheim
Catalent Inc.
Famar S.A.
Hospira, Inc.
Jubilant Life Sciences Ltd.
Lonza Group
Patheon Inc.
Pfizer CentreSource
Recipharm AB
Vetter Pharma International GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of Global Market by Category 43
3.1 Market Overview by Category 43
3.2 Pharmaceutical Industry 45
3.3 Biopharmaceutical Industry 46
4 Segmentation of Global Market by Product 47
4.1 Market Overview by Product 47
4.2 Active Pharmaceutical Ingredients (API) 49
4.2.1 Branded API Manufacturing 50
4.2.2 Generic API Manufacturing 51
4.3 Finished Dosage Formulations (FDF) 52
4.3.1 Solid Dosage 54
4.3.2 Oral Liquids 55
4.3.3 Parenteral/Injectables 56
4.3.4 Other FDFs 57
4.4 Secondary Packaging 58
5 Segmentation of Global Market by Phase 59
5.1 Market Overview by Phase 59
5.2 Clinical Manufacturing 61
5.3 Commercial Manufacturing 62
6 Segmentation of Global Market by Type 63
6.1 Market Overview by Type 63
6.2 Sterile Products 65
6.3 Non-Sterile Products 66
7 Segmentation of Global Market by Therapeutic Application 67
7.1 Market Overview by Therapeutic Application 67
7.2 Infectious Diseases 69
7.3 Oncology 70
7.4 Metabolic Disorders 71
7.5 Cardiovascular Disorders 72
7.6 Central Nervous System 73
7.7 Pulmonary Disorders 74
7.8 Gastrointestinal Disorders 75
7.9 Other Therapeutic Applications 76
8 Segmentation of Global Market by Region 77
8.1 Geographic Market Overview 2019-2030 77
8.2 North America Market 2019-2030 by Country 81
8.2.1 Overview of North America Market 81
8.2.2 U.S. 85
8.2.3 Canada 89
8.2.4 Mexico 91
8.3 European Market 2019-2030 by Country 93
8.3.1 Overview of European Market 93
8.3.2 Germany 97
8.3.3 UK 99
8.3.4 France 101
8.3.5 Spain 103
8.3.6 Italy 105
8.3.7 Russia 107
8.3.8 Rest of European Market 109
8.4 Asia-Pacific Market 2019-2030 by Country 111
8.4.1 Overview of Asia-Pacific Market 111
8.4.2 Japan 115
8.4.3 China 118
8.4.4 Australia 121
8.4.5 India 123
8.4.6 South Korea 125
8.4.7 Rest of APAC Region 127
8.5 South America Market 2019-2030 by Country 129
8.5.1 Argentina 132
8.5.2 Brazil 134
8.5.3 Chile 136
8.5.4 Rest of South America Market 138
8.6 MEA Market 2019-2030 by Country 139
8.6.1 UAE 142
8.6.2 Saudi Arabia 144
8.6.3 South Africa 146
8.6.4 Other National Markets 148
9 Competitive Landscape 149
9.1 Overview of Key Vendors 149
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Aenova Group 154
Baxter BioPharma Solutions 156
Boehringer Ingelheim 157
Catalent Inc. 158
Famar S.A. 159
Hospira, Inc. 160
Jubilant Life Sciences Ltd. 161
Lonza Group 162
Patheon Inc. 163
Pfizer CentreSource 164
Recipharm AB 165
Vetter Pharma International GmbH 166
10 Investing in Global Market: Risk Assessment and Management 167
10.1 Risk Evaluation of Global Market 167
10.2 Critical Success Factors (CSFs) 170
Related Reports and Products 173

Key Players (this may not be a complete list and extra companies can be added upon request):
Aenova Group
Baxter BioPharma Solutions
Boehringer Ingelheim
Catalent Inc.
Famar S.A.
Hospira, Inc.
Jubilant Life Sciences Ltd.
Lonza Group
Patheon Inc.
Pfizer CentreSource
Recipharm AB
Vetter Pharma International GmbH
Table 1. Snapshot of Global Pharmaceutical Contract Manufacturing Market, 2019-2030 20
Table 2. Growth Rate of World Real GDP, 2017-2021 24
Table 3. Main Product Trends and Market Opportunities in Global Pharmaceutical Contract Manufacturing Market 34
Table 4. Global Pharmaceutical Contract Manufacturing Market by Category, 2019-2030, $ bn 43
Table 5. Global Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 47
Table 6. Global Pharmaceutical Contract Manufacturing Market: Active Pharmaceutical Ingredients (API) by Type, 2019-2030, $ bn 49
Table 7. Global Pharmaceutical Contract Manufacturing Market: Finished Dosage Formulations (FDF) by Type, 2019-2030, $ bn 53
Table 8. Global Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 59
Table 9. Global Pharmaceutical Contract Manufacturing Market by Type, 2019-2030, $ bn 63
Table 10. Global Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 67
Table 11. Global Pharmaceutical Contract Manufacturing Market by Region, 2019-2030, $ bn 78
Table 12. Leading National Pharmaceutical Contract Manufacturing Market, 2019 and 2030, $ bn 80
Table 13. North America Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn 83
Table 14. U.S. Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 87
Table 15. U.S. Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 87
Table 16. U.S. Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 87
Table 17. Canada Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 90
Table 18. Canada Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 90
Table 19. Canada Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 90
Table 20. Mexico Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 92
Table 21. Mexico Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 92
Table 22. Mexico Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 92
Table 23. Europe Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn 96
Table 24. Germany Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 98
Table 25. Germany Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 98
Table 26. Germany Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 98
Table 27. UK Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 100
Table 28. UK Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 100
Table 29. UK Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 100
Table 30. France Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 102
Table 31. France Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 102
Table 32. France Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 102
Table 33. Spain Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 104
Table 34. Spain Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 104
Table 35. Spain Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 104
Table 36. Italy Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 106
Table 37. Italy Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 106
Table 38. Italy Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 106
Table 39. Russia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 108
Table 40. Russia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 108
Table 41. Russia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 108
Table 42. Pharmaceutical Contract Manufacturing Market in Rest of Europe by Country, 2019-2030, $ bn 110
Table 43. APAC Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn 113
Table 44. Japan Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 117
Table 45. Japan Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 117
Table 46. Japan Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 117
Table 47. China Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 120
Table 48. China Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 120
Table 49. China Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 120
Table 50. Australia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 122
Table 51. Australia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 122
Table 52. Australia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 122
Table 53. India Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 124
Table 54. India Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 124
Table 55. India Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 124
Table 56. South Korea Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 126
Table 57. South Korea Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 126
Table 58. South Korea Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 126
Table 59. Pharmaceutical Contract Manufacturing Market in Rest of APAC by Country, 2019-2030, $ bn 128
Table 60. South America Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn 131
Table 61. Argentina Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 133
Table 62. Argentina Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 133
Table 63. Argentina Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 133
Table 64. Brazil Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 135
Table 65. Brazil Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 135
Table 66. Brazil Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 135
Table 67. Chile Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 137
Table 68. Chile Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 137
Table 69. Chile Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 137
Table 70. MEA Pharmaceutical Contract Manufacturing Market by Country, 2019-2030, $ bn 141
Table 71. UAE Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 143
Table 72. UAE Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 143
Table 73. UAE Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 143
Table 74. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 145
Table 75. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 145
Table 76. Saudi Arabia Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 145
Table 77. South Africa Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, $ bn 147
Table 78. U.S. Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, $ bn 147
Table 79. U.S. Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, $ bn 147
Table 80. Breakdown of Global Market by Key Vendor, 2019, % 151
Table 81. Aenova Group: Company Snapshot 154
Table 82. Aenova Group: Business Segmentation 154
Table 83. Aenova Group: Product Portfolio 155
Table 84. Aenova Group: Revenue, 2016-2018, $ bn 155
Table 85. Aenova Group: Recent Developments 155
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030 168
Table 87. Critical Success Factors and Key Takeaways 171
Figure 1. Research Method Flow Chart 13
Figure 2. Breakdown of Primary Research 15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 19
Figure 5. Global Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 22
Figure 6. Impact of COVID-19 on Business 26
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Contract Manufacturing Market 28
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical Contract Manufacturing Market 31
Figure 9. Investment Opportunity Analysis 35
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical Contract Manufacturing Market 38
Figure 11. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Category, 2019-2030, % of Revenue 44
Figure 12. Global Addressable Market Cap in 2020-2030 by Category, Value ($ bn) and Share (%) 44
Figure 13. Global Pharmaceutical Contract Manufacturing Market: Pharmaceutical Industry, 2019-2030, $ bn 45
Figure 14. Global Pharmaceutical Contract Manufacturing Market: Biopharmaceutical Industry, 2019-2030, $ bn 46
Figure 15. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Product, 2019-2030, % of Sales Revenue 48
Figure 16. Global Addressable Market Cap in 2020-2030 by Product, Value ($ bn) and Share (%) 48
Figure 17. Global Pharmaceutical Contract Manufacturing Market: Active Pharmaceutical Ingredients (API), 2019-2030, $ bn 49
Figure 18. Global Pharmaceutical Contract Manufacturing Market: Branded API Manufacturing, 2019-2030, $ bn 50
Figure 19. Global Pharmaceutical Contract Manufacturing Market: Generic API Manufacturing, 2019-2030, $ bn 51
Figure 20. Global Pharmaceutical Contract Manufacturing Market: Finished Dosage Formulations (FDF), 2019-2030, $ bn 52
Figure 21. Global Pharmaceutical Contract Manufacturing Market: Solid Dosage, 2019-2030, $ bn 54
Figure 22. Global Pharmaceutical Contract Manufacturing Market: Oral Liquids, 2019-2030, $ bn 55
Figure 23. Global Pharmaceutical Contract Manufacturing Market: Parenteral/Injectables, 2019-2030, $ bn 56
Figure 24. Global Pharmaceutical Contract Manufacturing Market: Other FDFs, 2019-2030, $ bn 57
Figure 25. Global Pharmaceutical Contract Manufacturing Market: Secondary Packaging, 2019-2030, $ bn 58
Figure 26. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Phase, 2019-2030, % of Sales Revenue 60
Figure 27. Global Addressable Market Cap in 2020-2030 by Phase, Value ($ bn) and Share (%) 60
Figure 28. Global Pharmaceutical Contract Manufacturing Market: Clinical Manufacturing, 2019-2030, $ bn 61
Figure 29. Global Pharmaceutical Contract Manufacturing Market: Commercial Manufacturing, 2019-2030, $ bn 62
Figure 30. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Type, 2019-2030, % of Revenue 64
Figure 31. Global Addressable Market Cap in 2020-2030 by Type, Value ($ bn) and Share (%) 64
Figure 32. Global Pharmaceutical Contract Manufacturing Market: Sterile Products, 2019-2030, $ bn 65
Figure 33. Global Pharmaceutical Contract Manufacturing Market: Non-Sterile Products, 2019-2030, $ bn 66
Figure 34. Breakdown of Global Pharmaceutical Contract Manufacturing Market by Therapeutic Application, 2019-2030, % of Revenue 68
Figure 35. Global Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%) 68
Figure 36. Global Pharmaceutical Contract Manufacturing Market: Infectious Diseases, 2019-2030, $ bn 69
Figure 37. Global Pharmaceutical Contract Manufacturing Market: Oncology, 2019-2030, $ bn 70
Figure 38. Global Pharmaceutical Contract Manufacturing Market: Metabolic Disorders, 2019-2030, $ bn 71
Figure 39. Global Pharmaceutical Contract Manufacturing Market: Cardiovascular Disorders, 2019-2030, $ bn 72
Figure 40. Global Pharmaceutical Contract Manufacturing Market: Central Nervous System, 2019-2030, $ bn 73
Figure 41. Global Pharmaceutical Contract Manufacturing Market: Pulmonary Disorders, 2019-2030, $ bn 74
Figure 42. Global Pharmaceutical Contract Manufacturing Market: Gastrointestinal Disorders, 2019-2030, $ bn 75
Figure 43. Global Pharmaceutical Contract Manufacturing Market: Other Therapeutic Applications, 2019-2030, $ bn 76
Figure 44. Global Market Snapshot by Region 77
Figure 45. Geographic Spread of Worldwide Pharmaceutical Contract Manufacturing Market, 2019-2030, % of Sales Revenue 78
Figure 46. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%) 79
Figure 47. North American Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 82
Figure 48. Breakdown of North America Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue 83
Figure 49. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 84
Figure 50. U.S. Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 86
Figure 51. Canada Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 89
Figure 52. Pharmaceutical Contract Manufacturing Market in Mexico, 2015-2030, $ bn 91
Figure 53. European Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 94
Figure 54. Breakdown of European Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue 95
Figure 55. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 96
Figure 56. Pharmaceutical Contract Manufacturing Market in Germany, 2019-2030, $ bn 97
Figure 57. Pharmaceutical Contract Manufacturing Market in UK, 2019-2030, $ bn 99
Figure 58. Pharmaceutical Contract Manufacturing Market in France, 2019-2030, $ bn 101
Figure 59. Pharmaceutical Contract Manufacturing Market in Spain, 2019-2030, $ bn 103
Figure 60. Pharmaceutical Contract Manufacturing Market in Italy, 2019-2030, $ bn 105
Figure 61. Pharmaceutical Contract Manufacturing Market in Russia, 2019-2030, $ bn 107
Figure 62. Pharmaceutical Contract Manufacturing Market in Rest of Europe, 2019-2030, $ bn 109
Figure 63. Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 112
Figure 64. Breakdown of APAC Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue 112
Figure 65. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 114
Figure 66. Pharmaceutical Contract Manufacturing Market in Japan, 2019-2030, $ bn 116
Figure 67. Pharmaceutical Contract Manufacturing Market in China, 2019-2030, $ bn 119
Figure 68. Pharmaceutical Contract Manufacturing Market in Australia, 2019-2030, $ bn 121
Figure 69. Pharmaceutical Contract Manufacturing Market in India, 2019-2030, $ bn 123
Figure 70. Pharmaceutical Contract Manufacturing Market in South Korea, 2019-2030, $ bn 125
Figure 71. Pharmaceutical Contract Manufacturing Market in Rest of APAC, 2019-2030, $ bn 127
Figure 72. South America Pharmaceutical Contract Manufacturing Market, 2019-2030, $ bn 130
Figure 73. Breakdown of South America Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue 130
Figure 74. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 131
Figure 75. Pharmaceutical Contract Manufacturing Market in Argentina, 2019-2030, $ bn 132
Figure 76. Pharmaceutical Contract Manufacturing Market in Brazil, 2019-2030, $ bn 134
Figure 77. Pharmaceutical Contract Manufacturing Market in Chile, 2019-2030, $ bn 136
Figure 78. Pharmaceutical Contract Manufacturing Market in Rest of South America, 2019-2030, $ bn 138
Figure 79. Pharmaceutical Contract Manufacturing Market in Middle East and Africa (MEA), 2019-2030, $ bn 140
Figure 80. Breakdown of MEA Pharmaceutical Contract Manufacturing Market by Country, 2019 and 2030, % of Revenue 140
Figure 81. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 141
Figure 82. Pharmaceutical Contract Manufacturing Market in UAE, 2019-2030, $ bn 142
Figure 83. Pharmaceutical Contract Manufacturing Market in Saudi Arabia, 2019-2030, $ bn 144
Figure 84. Pharmaceutical Contract Manufacturing Market in South Africa, 2019-2030, $ bn 146
Figure 85. Growth Stage of Global Pharmaceutical Contract Manufacturing Industry over the Forecast Period 149

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.